Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Influenza
 More »

  • Influenza and Coronavirus Pandemic Preparedness Asia 2013
    Singapore SINGAPORE www.pandemicasia.com
    10-23-2013
  • Vivaldi Buys Flu Vaccine R&D Assets from Baxter
    property, clinical data, knowhow, and materials-for live attenuated influenza vaccines (LAIVs) in which the gene for influenza nonstructural protein 1 (NS1) has been fully deleted. ...
    10-10-2013
  • J&J's Janssen Companies Launch a Trio of Collaborations
    the development of an influenza vaccine using CureVac's RNActive® technology platform. ... will build on CureVac's preclinical influenza studies, published in Nature ...
    10-3-2013
  • Advertorial: Advanced BioScience Laboratories (ABL)
    nonprofit, and commercial research groups developing vaccines and therapeutics against a wide range of diseases including HIV, dengue, tuberculosis, malaria, cancer, and influenza. ...
    10-1-2013
  • Nanoparticles Show Promise for Vaccine Delivery to Lungs
    Such vaccines could help protect against influenza and other respiratory viruses, or prevent sexually transmitted diseases such as HIV, herpes simplex virus, and human papilloma ...
    9-26-2013
  • Researchers Chafe as NIH Budgets Shrivel
    ... of adeno-associated viral (AAV) vectors as countermeasures for pandemic respiratory infections such as those caused by influenza viruses. Securing DoD funding required Dr. ...
    9-11-2013
  • AAV Vectors for Infectious Diseases
    for pandemic respiratory infections such as those caused by influenza viruses. ... Pandemic Influenza The 2009 H1N1 pandemic demonstrated that the time required to generate, ...
    9-1-2013
  • Biopharmas Drive Antibiotic Development
    ... Four of the six compounds were in-licensed or developed through collaborations. Relenza, an intravenous neuraminidase inhibitor for influenza, is the most advanced. The targets of ...
    9-1-2013
  • GSK Wins FDA Approval for FluLaval Quadrivalent
    GlaxoSmithKline (GSK) won FDA approval for its FluLaval® Quadrivalent influenza virus ... that constitute the four primary influenza strains known to cause the majority of ...
    8-16-2013
  • Neutralizing Antibodies Key to Broad Anti-Flu Immunity
    against previously encountered influenza A viruses (IAVs) affects the outcome of ... This constant antigenic drift is the reason that influenza pandemics remain one of the ...
    8-13-2013
  • Getting Ready for the Flu
    of deaths in the United States attributed to pneumonia or influenza peaked at 9.9%. ... Trivalent and Quadrivalent Vaccines Available While the 2013-2014 trivalent influenza ...
    8-13-2013
  • Biopharmas Drive Antibiotic Development
    ... Four of the six compounds were in-licensed or developed through collaborations. Relenza, an intravenous neuraminidase inhibitor for influenza, is the most advanced. The targets of ...
    8-9-2013
  • Big Need in IBD: Drugs to Slow Progression
    ... A study also is being planned to evaluate the immunogenicity of influenza vaccines in relationship to maintenance infliximab dosing. Janssen also is recruiting patients for a Phase ...
    8-1-2013
  • PharmAthene, Theraclone Agree to Merger
    of human cytomegalovirus (HCMV) infections, and TCN-032 influenza antibody for pandemic and severe seasonal influenza-plus another mAb, PharmAthene's Valortim® anthrax ...
    8-1-2013
  • Just How Versatile Is the Polymerase Chain Reaction?
    The CDC list 20 different PCR-based tests approved for influenza detection and in some ... de novo the H7N9 genes to a strain of influenza, they were able to generate MDCK cells ...
    7-25-2013
  • More »

    Journal Articles

  • Influenza B Virus Causes Milder Pathogenesis and Weaker Inflammatory...
    Yun Hee Kim, Hyun Soo Kim, Sung Hwan Cho, Sang Heui Seo
    Viral Immunology
    Influenza B Virus Causes Milder Pathogenesis and Weaker Inflammatory Responses in Ferrets Than Influenza A Virus Viral Immunology Abstract It is unknown why the influenza B virus ...
  • Universal Influenza Vaccination: The Time to Act Is Now
    Michael Mair, Robert W. Grow, Julie Samia Mair, Lewis J. Radonovich
    Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science
    Universal Influenza Vaccination: The Time to Act Is Now Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science Annual influenza epidemics create a significant ...
  • Influenza and Pregnant Women: Hospitalization Burden, United...
    Shanna Cox, Samuel F. Posner, Melissa McPheeters, Denise J. Jamieson, Athena P. Kourtis, Susan Meikle
    Journal of Women's Health
    Influenza and Pregnant Women: Hospitalization Burden, United States, 1998-2002 Journal of ... Women in later stages of pregnancy are at increased risk for serious influenza-related ...
  • Seasonal Influenza Vaccine Coverage Among Pregnant Women: Pregnancy...
    Indu B. Ahluwalia, James A. Singleton, Denise J. Jamieson, Sonja A. Rasmussen, Leslie Harrison
    Journal of Women's Health
    Seasonal Influenza Vaccine Coverage Among Pregnant Women: Pregnancy Risk Assessment ... pregnant women receive the seasonal influenza vaccine, regardless of pregnancy ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Balancing Family and Career for Women Ph.D.s

Which changes made to academic culture are most likely to encourage women researchers to stay?

Suggest a Poll